Literature DB >> 25847891

Smoking, diabetes, blood hypertension: possible etiologic role for Peyronie's disease? Analysis in 279 patients with a control group in Sicily.

Carlo Pavone1, Francesco D'Amato, Nino Dispensa, Federico Torretta, Carlo Magno.   

Abstract

OBJECTIVE: To assess the proportion of patients with Peyronie's Disease (PD) and the possible association with its potential risk factors in the general population of the central and western Sicily in our weekly andrological outpatient clinic.
MATERIALS AND METHODS: We recruited a sample of 279 consecutive patients consulting our andrological outpatient clinic. Two arms were created: the first one composed by PD patients (men with symptoms suggestive for PD), the second one composed by patients with other andrological diseases (control arm). For each patient we evaluated the age, cigarette smoking, diabetes, blood hypertension and erectile function. In the PD arm we administered validated questionnaires to determine the erectile function status by the International Index of Erectile Function 5 (IIEF-5) and the pain status during erection by the Visual Analogue Scale (VAS). A univariate analysis was conducted using R software.
RESULTS: We enrolled 279 consecutive patients. The number of PD patients was 97 (34,7%). The univariate analysis showed a correlation between PD and cigarette smoking (p = 0.0242), blood hypertension (p < 0.001), erectile dysfunction (p < 0.001). No significant association was observed between diabetes and PD (p = 0.358). The median age of PD arm was 60 years and the median age of the control arm was 63,5 years; therefore the median age of PD arm resulted lower than the median age of the control arm (p = 0,031).
CONCLUSIONS: Peyronie's disease is more common than we might think; furthermore it can be diagnosed among young patients. According to our results, cigarette smoking and blood hypertension may be considered statically significant risk factors for developing PD. On the contrary diabetes seems not to be a risk factor for PD. According to our results PD should be sought also in young patients. Further studies are necessary to confirm that removing the indicated risk factors may reduce the incidence of PD.

Entities:  

Mesh:

Year:  2015        PMID: 25847891     DOI: 10.4081/aiua.2015.1.20

Source DB:  PubMed          Journal:  Arch Ital Urol Androl        ISSN: 1124-3562


  5 in total

1.  Laser Therapy for Peyronie's Disease: A Randomized Control Double-Blind Pilot Study.

Authors:  Farzad Allameh; Mohammadreza Razzaghi; Seyed Mansoor Rayegani; Morteza Fallah-Karkan; Arash Ranjbar; Amirhosein Rahavian; Atefeh Javadi; Saleh Ghiasy; Zahra Razzaghi
Journal:  J Lasers Med Sci       Date:  2019-12-01

2.  Significant familial clustering of Peyronie's disease in close and distant relatives.

Authors:  Kristina L Allen-Brady; Michael B Christensen; Ashlynn D Sandberg; Alexander W Pastuszak
Journal:  Andrology       Date:  2022-07-13       Impact factor: 4.456

3.  Diagnosis and treatment patterns of Peyronie's disease among different racial, ethnic, and regional groups in the Veterans Affairs healthcare system.

Authors:  Sirpi Nackeeran; Isaac Zucker; Iakov Efimenko; Alexander Weber; Scott C Brown; Ranjith Ramasamy; Thomas Masterson
Journal:  Int J Impot Res       Date:  2022-09-23       Impact factor: 2.408

Review 4.  A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease.

Authors:  L Gao; S Qian; Z Tang; J Li; J Yuan
Journal:  Int J Impot Res       Date:  2016-06-02       Impact factor: 2.896

5.  Prevalence of Peyronie's Disease-Like Symptoms in Men Presenting With Dupuytren Contractures.

Authors:  Alan W Shindel; Genevieve Sweet; William Thieu; Blythe Durbin-Johnson; Jennifer Rothschild; Robert Szabo
Journal:  Sex Med       Date:  2017-07-01       Impact factor: 2.491

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.